Cite
HARVARD Citation
Hyams, J. et al. (2022). Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study. Journal of Crohn's and colitis. pp. 1243-1254. [Online].